Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02229604Phase 1Completed
Phase 1, open-label trial (2 arms), sponsored by Guang'anmen Hospital. Primary endpoint: Follicle-Stimulating Hormone at 12 weeks. Started Jan 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02229604.